This consumer information sheet from the CDC lays out the step-by-step basics of cleaning a syringe in order to prevent the transmission of hepatitis. Geared towards injection drug users, it emphasizes that viral hepatitis can survive on surfaces like cookers. Download, print and share the information sheet here!
Commissioner Farley named improving Hepatitis C prevention and treatment as one of the two strategic goals of the Division of Disease Control in his testimony on the Department of Public Health’s Fiscal Year 2019 Operating Budget. Specifically, the Division of Disease Control will aim to “increase the proportion of reported Read more…
This May, the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) updated their HCV screening and treatment recommendations to focus on eradicating HCV among key populations; including pregnant women who previously were not regularly screened, people who inject drugs, men who Read more…
Calling all investigators focused on addressing elimination in HIV/HCV co-infected and high-risk individuals! Gilead’s HIV/HCV No Co-Infection (NoCo) Program intends to support these micro-elimination efforts by giving up to $600,000 per research proposal. The Letter of Intent submission window closes Monday 8/20. To find out more about the HIV/HCV NoCo Program, Read more…
Philadelphia’s Path Towards HCV Elimination
The O’Neill Institute of Georgetown Law School has released a report highlighting the stories of women and men who have faced Hepatitis C. A publication by the Hepatitis Policy Project, “Full of Life: The Stories of People Affected by Hepatitis C” reveals the human impacts of treatment and policy, and Read more…
Access Minutes Here The Committee reviewed the Hepatitis C Agents class and unaminously approved adding Mavyret to the PDL at preferred status, moving Pegasys, Pegintron, Sovaldi, Technivie, Viekira Pak and Viekira XR to non-preferred status, and adding Vosevi to the PDL at non-preferred status. The Committee recognized the changing landscape Read more…
The Franklin Institute has done a highlight article of our Community Co-Chair Stacey! ” PHILADELPHIA WOMEN IN SCIENCE May is Hepatitis Awareness Month, so it’s fitting that our Women in Science series features infectious disease specialist Dr. Stacey Trooskin, who is helping lead Philadelphia’s charge to eliminate hepatitis C from Read more…
Community Health Fair to raise awareness of Hepatitis. Get TESTED! Location: 2539 Germantown Ave, Philadelphia, PA 19133, USA When: June 27th Contact: 215.225.5800
C a Difference is a comprehensive hepatitis C (HCV) testing and linkage-to-care program at Philadelphia FIGHT housed at the John Bell Health Center (JBHC). C A Difference will be offering testing on their van on the corner of 15th and JFK on May 10th and May 18th. On May 18th Read more…